Literature DB >> 24097331

Locally advanced prostate cancer: optimal therapy in older patients.

Michael Froehner1, Manfred P Wirth.   

Abstract

There is no standard treatment for locally advanced prostate cancer. Even the definition is still unclear. Locally advanced disease may refer to over-staged well-curable tumors as well as to advanced and probably incurable cancers. Similar uncertainties are present regarding the definition of 'old' in this context. Conservatively treated locally advanced prostate cancer is associated with poor survival outcome. With the increasing life expectancy, in the absence of curative treatment, even patients in their ninth decade of life may later suffer from symptoms of aggressive prostate cancer and are at a high risk of death from prostate cancer that might be prevented at least in part by early intervention. On the other hand, functional results after prostate cancer treatment are worse in elderly patients. In this article we discuss aspects of the management of locally advanced prostate cancer in the elderly with special focus on the recommendation of current clinical guidelines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24097331     DOI: 10.1007/s40266-013-0123-7

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  48 in total

1.  Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

Authors:  James W Denham; Allison Steigler; David S Lamb; David Joseph; Sandra Turner; John Matthews; Chris Atkinson; John North; David Christie; Nigel A Spry; Keen-Hun Tai; Chris Wynne; Catherine D'Este
Journal:  Lancet Oncol       Date:  2011-05       Impact factor: 41.316

2.  Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.

Authors:  Olof Akre; Hans Garmo; Jan Adolfsson; Mats Lambe; Ola Bratt; Pär Stattin
Journal:  Eur Urol       Date:  2011-06-01       Impact factor: 20.096

3.  Impact of age at diagnosis on prostate cancer treatment and survival.

Authors:  Seth K Bechis; Peter R Carroll; Matthew R Cooperberg
Journal:  J Clin Oncol       Date:  2010-12-06       Impact factor: 44.544

4.  Locally advanced prostate cancer: a population-based study of treatment patterns.

Authors:  William T Lowrance; Elena B Elkin; David S Yee; Andrew Feifer; Behfar Ehdaie; Lindsay M Jacks; Coral L Atoria; Michael J Zelefsky; Howard I Scher; Peter T Scardino; James A Eastham
Journal:  BJU Int       Date:  2011-11-15       Impact factor: 5.588

Review 5.  Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials.

Authors:  Daniel A Hamstra; Kyounghwa Bae; Miljenko V Pilepich; Gerald E Hanks; David J Grignon; David G McGowan; Mack Roach; Colleen Lawton; R Jeffrey Lee; Howard Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-31       Impact factor: 7.038

Review 6.  Optimal treatment of locally advanced prostate cancer.

Authors:  Manfred P Wirth; Oliver W Hakenberg; Michael Froehner
Journal:  World J Urol       Date:  2007-02-27       Impact factor: 4.226

7.  Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

Authors:  Michel Bolla; Laurence Collette; Léo Blank; Padraig Warde; Jean Bernard Dubois; René-Olivier Mirimanoff; Guy Storme; Jacques Bernier; Abraham Kuten; Cora Sternberg; Johan Mattelaer; José Lopez Torecilla; J Rafael Pfeffer; Carmel Lino Cutajar; Alfredo Zurlo; Marianne Pierart
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

8.  Extended followup oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2c-T3b).

Authors:  Joseph L Chin; Ali A Al-Zahrani; Ana Maria Autran-Gomez; Andrew K Williams; Glenn Bauman
Journal:  J Urol       Date:  2012-08-15       Impact factor: 7.450

Review 9.  Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.

Authors:  Jean-Pierre Droz; Lodovico Balducci; Michel Bolla; Mark Emberton; John M Fitzpatrick; Steven Joniau; Michael W Kattan; Silvio Monfardini; Judd W Moul; Arash Naeim; Hendrik van Poppel; Fred Saad; Cora N Sternberg
Journal:  Crit Rev Oncol Hematol       Date:  2010-01       Impact factor: 6.312

10.  Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy.

Authors:  Inga Kunz; Michael Musch; Ulla Roggenbuck; Virgilijus Klevecka; Darko Kroepfl
Journal:  BJU Int       Date:  2012-09-05       Impact factor: 5.588

View more
  2 in total

1.  [Organ and function preservation in prostate cancer].

Authors:  M Fröhner; M Wirth
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

Review 2.  Senescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.

Authors:  Gianluigi Taverna; Mauro Seveso; Guido Giusti; Rodolfo Hurle; Pierpaolo Graziotti; Sanja Stifter; Maurizio Chiriva-Internati; Fabio Grizzi
Journal:  Curr Gerontol Geriatr Res       Date:  2014-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.